Advertisement

EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy

EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy

The European Commission has joined the Food and Drug Administration in accepting Zejula as a front-line therapy.